NET G3 express somatostatin receptor 2 (SSTR2) in 70%–85%, which is comparable to that of NET G1/G2 and significantly higher than that of NEC.5, 7, 8. The gene discussed is SSTR2; the disease is neuroendocrine carcinoma.